Stem Point Capital LP Edgewise Therapeutics, Inc. Transaction History

Stem Point Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$22.0 - $30.03 $1.05 Million - $1.43 Million	47,549 Added 35.83%	180,255 $3.97 Billion
Q4 2024 Feb 14, 2025	BUY	$26.63 - $36.62 $3 Million - $4.13 Million	112,806 Added 566.86%	132,706 $3.54 Billion
Q3 2024 Nov 13, 2024	SELL	$15.88 - $29.5 $3.99 Million - $7.41 Million	-251,157 Reduced 92.66%	19,900 $531 Million
Q2 2024 Aug 13, 2024	BUY	$15.08 - $21.23 $4.09 Million - $5.75 Million	271,057 New	271,057 $4.88 Billion

186

112M

188K

121K

Ticker EWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,171,700
Market Cap $1.44B
Description
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...

Get notified when there are updates to the investment portfolio of Stem Point Capital LP, based on Form 13F filings with the SEC.

Stay updated on Stem Point Capital LP with notifications on news.